Fundraising Fox
/Companies
Sign in

Quinn

YC S22

San Francisco, US · Founded 2022 · 5 employees · 14 known investors

Find your way into Quinn

Sign up to see every warm intro you have to Quinn

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Quinn team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.

Also known as iollo, Inc. · iollo

AI & Machine LearningBiotechDeep TechHealthtechArtificial IntelligenceGenerative AIEnterpriseUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S22)

Quinn was founded in 2022 by Daniel Gomari and Michael Snyder.

DGDaniel Gomari
Daniel GomariFounder and CEODaniel Gomari holds a PhD in Computational Biology and completed a postdoctoral fellowship at Stanford, where he conducted research on machine learning applications in drug repurposing for cancer and metabolic disease, and multi-omics studies on aging. He founded Quinn to address pharmaceutical R&D processes.
MSMichael Snyder
Michael SnyderCo-founder, PhD, Chair of Genetics at Stanford
EB
Elisa BenedettiScience Lead
KR
Katherine ReyesOps
BLBrent LaRue
Brent LaRueCo-founder, CPO2022–2022Founder/VP Product & Patient Experience at Circle Medical

Investors · 14

Amino CapitalreportedPalo Alto · $100K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Babel VenturesreportedSan Francisco · $100K – $3M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

FAST — by GETTYLABreportedSan Francisco · $100K

How we know: Y Combinator's founder network · Not right? Tell us

Fundament Syndicatereported

How we know: Y Combinator's founder network · Not right? Tell us

Goodwater CapitalreportedBurlingame · $5M – $50M

How we know: Y Combinator's founder network · Not right? Tell us

Hummingbird VenturesreportedBrussels · $500K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Palrecha Capital RollingreportedSeattle

How we know: Y Combinator's founder network · Not right? Tell us

Paradox CapitalreportedLynnwood

How we know: Y Combinator's founder network · Not right? Tell us

Peterson Venture PartnersreportedSalt Lake City · $5M – $25M

How we know: Y Combinator's founder network · Not right? Tell us

PioneerreportedToronto, Ontario

How we know: Y Combinator's founder network · Not right? Tell us

Red Rooster VenturesreportedSan Mateo

How we know: Y Combinator's founder network · Not right? Tell us

Sequoia CapitalreportedMenlo Park · $100K – $50M

How we know: Y Combinator's founder network · Not right? Tell us

VentureSouqreportedAbu Dhabi · $100K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Maven BioMaven Bio provides software for biotech investment firms to accelerate due diligence and thesis development, automating screening, competitive analysis, and clinical data review to compress research timelines from days to hours.
Synthio LabsSynthio Labs develops AI-powered synthesis and clinical interpretation systems for pharmaceutical interactions, offering text, voice, and video interfaces designed for healthcare professionals and patients that integrate FDA labels, drug mechanisms, and clinical literature.
Science ExchangeScience Exchange provides operational infrastructure for life sciences R&D, connecting organizations, suppliers, and workflows to streamline contracting, compliance, onboarding, and financial coordination across the research ecosystem.
Credal.aiCredal provides a platform for managing AI agents with administrative visibility and team access controls. The product serves organizations deploying multiple agents.
InariInari analyzes customer feedback, support tickets, and CRM data to identify product opportunities and customer insights, automatically surfacing relevant information and linking findings to backlog items.

Companies working in the same space as Quinn.

Legal entities · 1

corporate structure
iollo, Inc.

Frequently asked questions

What does Quinn do?
Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.
Who founded Quinn?
Quinn was founded by Daniel Gomari, Michael Snyder in 2022.
Who are Quinn's investors?
Quinn's investors include Y Combinator, Amino Capital, Babel Ventures, FAST — by GETTYLAB, Fundament Syndicate, Goodwater Capital, Hummingbird Ventures, Palrecha Capital Rolling and 6 more.
Where is Quinn headquartered?
Quinn is headquartered in San Francisco, US.